Skip Navigation

European Heart Journal 1997 18(4):649-654;
Copyright © 1997 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1997 The European Society of Cardiology

Intravenous digoxin in acute atrial fibrillation

Results of a randomized, placebo-controlled multicentre trial in 239 patients

The Digitalis in Acute Atrial Fibrillation (DAAF) Trial Group

revised 30 September 1996; accepted 21 October 1996.

Correspondence: Björn Hornestam, MD, Division of Cardiology, Department of Internal Medicine, Östra University Hospital, S-416 85 Göteborg, Sweden

Abstract

AIMS: The DAAF Trial was designed to investigate whether digoxin, within 16 h of its use, increases the rate of conversion to sinus rhythm in patients with acute atrial fibrillation.

METHODS AND RESULTS: In a randomized, double-blind multicentre trial the effects of intravenous digoxin and placebo, (mean dose 0·88±0·35 mg and 0·96±0·37 mg) were compared in 239 patients with a mean age of 66·2±13·0 years and atrial fibrillation of, at most, 7 days' duration. The mean arrhythmia duration was 21·7±30·4 h and baseline heart rate 122·0±23·0 beats. min–1. At 16 h, 46% of the placebo group and 51% of the digoxin group had converted to sinus rhythm, (ns). Time to sinus rhythm was shorter in the digoxin group, but the difference was not significant. Digoxin had a pronounced and rapid effect on heart rate, which was already significant at 2 h; 104·6±20·9 beats. min–1 vs 116·8±22·5 beats. min–1 (P=0·0001).

CONCLUSION: Acute intravenous treatment with digoxin does not increase the rate of conversion to sinus rhythm, but has a fast acting and clinically significant effect on heart rate and should remain an alternative in haemodynamically stable patients

Key Words: Atrial fibrillation • digoxin • controlled clinical trial • therapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
ChestHome page
C. W. Khoo and G. Y. H. Lip
Acute Management of Atrial Fibrillation
Chest, March 1, 2009; 135(3): 849 - 859.
[Abstract] [Full Text] [PDF]


Home page
ESC Textbook of Cardiovascular MedicineHome page
A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst
CHAPTER 29 Atrial Fibrillation
ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
N Sulke, F Sayers, G Y H Lip, and on behalf of the Guideline Development Group for t
Rhythm control and cardioversion
Heart, January 1, 2007; 93(1): 29 - 34.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): 854 - 906.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): e257 - e354.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): 700 - 752.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Eur. Heart J., August 2, 2006; 27(16): 1979 - 2030.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
B. J. Dixon, Y. Bracha, S. W. Loecke, M. A. Guerrero, R. D. Taylor, and R. W. Asinger
Principal Atrial Fibrillation Discharges by the New ACC/AHA/ESC Classification
Arch Intern Med, September 12, 2005; 165(16): 1877 - 1881.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. V. Mattioli, S. Bonatti, M. Zennaro, and G. Mattioli
The relationship between personality, socio-economic factors, acute life stress and the development, spontaneous conversion and recurrences of acute lone atrial fibrillation
Europace, January 1, 2005; 7(3): 211 - 220.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
C-J A Lindholm, O Fredholm, S-J Moller, N Edvardsson, T Kronvall, T Pettersson, V Firsovaite, A Roijer, C J Meurling, P G Platonov, et al.
Sinus rhythm maintenance following DC cardioversion of atrial fibrillation is not improved by temporary precardioversion treatment with oral verapamil
Heart, May 1, 2004; 90(5): 534 - 538.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. Olshansky, L. E. Rosenfeld, A. L. Warner, A. J. Solomon, G. O'Neill, A. Sharma, E. Platia, G. K. Feld, T. Akiyama, M. A. Brodsky, et al.
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: Approaches to control rate in atrial fibrillation
J. Am. Coll. Cardiol., April 7, 2004; 43(7): 1201 - 1208.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
D. S. Chutka, P. Y. Takahashi, and R. W. Hoel
Inappropriate Medications for Elderly Patients
Mayo Clin. Proc., January 1, 2004; 79(1): 122 - 139.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
V. Snow, K. B. Weiss, M. LeFevre, R. McNamara, E. Bass, L. A. Green, K. Michl, D. K. Owens, J. Susman, D. I. Allen, et al.
Management of Newly Detected Atrial Fibrillation: A Clinical Practice Guideline from the American Academy of Family Physicians and the American College of Physicians
Ann Intern Med, December 16, 2003; 139(12): 1009 - 1017.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. L. McNamara, L. J. Tamariz, J. B. Segal, and E. B. Bass
Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography
Ann Intern Med, December 16, 2003; 139(12): 1018 - 1033.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
R. R Kasliwal, S. Mukesh, G. Manohar, N. Aggarwal, and A. Bhatia
Pharmacotherapy of Atrial Fibrillation
Asian Cardiovasc Thorac Ann, December 1, 2003; 11(4): 364 - 374.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
A Wakai and J O O'Neill
Emergency management of atrial fibrillation
Postgrad. Med. J., June 1, 2003; 79(932): 313 - 319.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
L. M. Letelier, K. Udol, J. Ena, B. Weaver, and G. H. Guyatt
Effectiveness of Amiodarone for Conversion of Atrial Fibrillation to Sinus Rhythm: A Meta-analysis
Arch Intern Med, April 14, 2003; 163(7): 777 - 785.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G Nichol, F McAlister, B Pham, A Laupacis, B Shea, M Green, A Tang, and G Wells
Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation
Heart, June 1, 2002; 87(6): 535 - 543.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al.
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
Circulation, October 23, 2001; 104(17): 2118 - 2150.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
Eur. Heart J., October 2, 2001; 22(20): 1852 - 1923.
[PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, R. W. Asinger, D. S. Cannom, H. J. Crijns, R. L. Frye, J. L. Halperin, G. N. Kay, W. W. Klein, S. Levy, et al.
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1266 - 1266.
[Full Text] [PDF]


Home page
NEJMHome page
R. H. Falk
Atrial Fibrillation
N. Engl. J. Med., April 5, 2001; 344(14): 1067 - 1078.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
I. A. Khan
Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation
J. Am. Coll. Cardiol., February 1, 2001; 37(2): 542 - 547.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
N. Wattanasuwan, I. A. Khan, N. J. Mehta, P. Arora, N. Singh, B. C. Vasavada, and T. J. Sacchi
Acute Ventricular Rate Control in Atrial Fibrillation : IV Combination of Diltiazem and Digoxin vs IV Diltiazem Alone
Chest, February 1, 2001; 119(2): 502 - 506.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
H.H. Veloso and A.A.V. De Paola
Clinical trials for conversion of recent onset atrial fibrillation must consider the role of digoxin
Eur. Heart J., December 2, 2000; 21(24): 2080 - 2081.
[PDF]


Home page
Eur Heart JHome page
A.U Khand, A.C Rankin, G.C Kaye, and J.G.F Cleland
Systematic review of the management of atrial fibrillation in patients with heart failure
Eur. Heart J., April 2, 2000; 21(8): 614 - 632.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.